BRIEF published on 04/07/2026 at 19:35, 1 month ago GENFIT makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document Liver Diseases GENFIT
BRIEF published on 04/07/2026 at 19:35, 1 month ago Mise à disposition du Document d’Enregistrement Universel 2025 par GENFIT AMF Biopharmaceutique GENFIT Document D’enregistrement Maladies Du Foie
BRIEF published on 04/07/2026 at 19:35, 1 month ago GENFIT publie le document d'enregistrement universel 2025 GENFIT Maladies Du Foie Document D'immatriculation 2025 Approbation Iqirvo® Portefeuille De R&D
BRIEF published on 04/07/2026 at 19:35, 1 month ago GENFIT Releases 2025 Universal Registration Document Liver Diseases GENFIT R&D Portfolio 2025 Registration Document Iqirvo® Approval
PRESS RELEASE published on 04/07/2026 at 19:30, 1 month ago GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025 GENFIT annonce la disponibilité de son Document d’Enregistrement Universel 2025 auprès de l’AMF. Détails financiers et gouvernance inclus. La société vise l'amélioration des maladies rares du foie AMF Maladies Rares GENFIT Foie Document D’Enregistrement Universel 2025
PRESS RELEASE published on 04/07/2026 at 19:30, 1 month ago GENFIT Announces Publication of the 2025 Universal Registration Document GENFIT announces the publication of the 2025 Universal Registration Document, providing key financial and corporate governance information. Available for public viewing and download on GENFIT and AMF websites Biopharmaceutical Company Financial Report Liver Diseases GENFIT 2025 Universal Registration Document
BRIEF published on 02/12/2026 at 18:40, 2 months 23 days ago GENFIT welcomes a $20M milestone payment thanks to Iqirvo® performance Biopharmaceutical GENFIT Ipsen Iqirvo® Stage Payment
BRIEF published on 02/12/2026 at 18:40, 2 months 23 days ago GENFIT Secures US$20M Milestone with Iqirvo® Success Clinical Trials Biopharmaceutical GENFIT Milestone Payment Iqirvo
BRIEF published on 02/12/2026 at 18:40, 2 months 23 days ago GENFIT franchit le cap des 20 millions de dollars grâce au succès d'Iqirvo® Biopharmaceutique Essais Cliniques GENFIT Paiement D'étape Iqirvo
BRIEF published on 02/12/2026 at 18:40, 2 months 23 days ago GENFIT accueille un paiement d'étape de 20 M$ grâce aux performances d'Iqirvo® Biopharmaceutique GENFIT Paiement D'étape Ipsen Iqirvo®
Published on 05/08/2026 at 00:00, 13 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 43 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 22:05, 2 hours 8 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 8 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 23:23, 49 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 58 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 7 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 30 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 4 hours 58 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 4 hours 58 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 6 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 6 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 13 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
